ONVO organovo.com Earnings growth forecast for next year

Corporate emblem and logo of Organovo (ONVO)

Can Organovo Holdings, Inc. (ONVO) maintain its leadership while losing ground to more dynamic competitors? The management's scientific potential has yet to translate into profit, although partnerships for 3D organ modeling for pharmaceutical testing are expanding. The projected EPS growth for the next fiscal year visualizes these expectations, and 0.00 captures the current value of the indicator.

Organovo Holdings Inc (ONVO): Expected net earnings per share growth next year from 07/04/2022 to 04/24/2025

ONVO (Organovo Holdings): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Initial company analysis:ONVO, organovo.com
Finished products of Organovo

Organovo Holdings, Inc. (ONVO) developments in 3D bioprinting of liver tissues determine the potential for future innovation monetization, which is directly reflected in market expectations. This trend in consensus earnings per share estimates measures the dynamics of projected EPS revisions, allowing investors to compare analyst optimism with the company's actual ability to generate cash flow and service its obligations during a period of active research.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year akerotx.com AKRO|Metsera Therapeutics (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Corp|89bio Pharma (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agios.com (AGIO)|Expected earnings per share growth for next year structuretx.com GPCR|Net earnings per share growth forecast for next year MiMedx Group Inc MDXG|Expected earnings per share trend next year RZLT|lexpharma.com - Earnings growth forecast for next year|MBX (MBX Biosciences Inc) - Projected earnings per share growth rate for next year|ALT: Earnings growth forecast for next year|Aardvark Therapeutics Inc - Expected earnings per share trend next year|SGMT (Sagimet Biosciences, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year BioAge|Earnings growth forecast for next year BMEA|Expected earnings per share growth for next year Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year VTVT|Agape ATP Corporation - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Pluri PLUR|SYBX: Earnings growth forecast for next year|Expected net earnings per share growth next year Lipocine Inc. (LPCN)|MTNB (Matinas BioPharma) - Earnings growth forecast for next year|sprucebiosciences.com (SPRB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Galecto Corp (GLTO)|CTCX - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Lumos Therapeutics LUMO|Radius Health (RDUS) - Expected net earnings per share growth next year